Role of CD14 and other innate immune receptors in severe sepsis
CD14 和其他先天免疫受体在严重脓毒症中的作用
基本信息
- 批准号:7755379
- 负责人:
- 金额:$ 38.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1989
- 资助国家:美国
- 起止时间:1989-01-01 至 2013-01-31
- 项目状态:已结题
- 来源:
- 关键词:1-Phosphatidylinositol 3-KinaseAddressAdult Respiratory Distress SyndromeAffectAntibioticsAntibodiesAreaBacteriaBacterial InfectionsBiological ProcessBiologyBloodBudgetsCD14 AntigenCD14 geneCell Adhesion MoleculesCell surfaceCellsClinicalCollaborationsComplexDNA SequenceDefectDevelopmentDiseaseDoseEncapsulatedEndothelial CellsEnzyme-Linked Immunosorbent AssayEscherichia coliEventExposure toFailureGene DeletionGenesGoalsGram-Negative BacteriaGrantGreater sac of peritoneumHealthHost DefenseHumanImmuneImmune responseImmunologic ReceptorsIndividualInfectionInfectious AgentInfiltrationInjection of therapeutic agentInvadedKnowledgeLeadLegal patentLifeMAP Kinase GeneMAPK14 geneMeasuresMediator of activation proteinMethodsMicrobeModelingMolecularMorbidity - disease rateMultiple Organ FailureMusMyeloid CellsNatural ImmunityNeutrophil InfiltrationOrgan failureOrganismOutcomePathway interactionsPatientsPeritoneal FluidPersonsPhagocytosisPlayPrincipal InvestigatorProcessProductionReagentRecruitment ActivityRegulationResearch DesignResearch PersonnelResistanceResistance to infectionRoleScientistSepsisSepsis SyndromeSeptic ShockSerumSignal PathwaySignaling MoleculeSiteTLR4 geneTNF geneTechnologyTestingTimeTissuesToll-Like Receptor 2Translational ResearchVertebratesVirulence FactorsWorkbacterial resistancebasecapsulechemokinecytokineexperiencekillingsmicroorganismmigrationmortalitymutantneutrophilnovelpreventprogramspublic health relevancereceptorresearch studyresponsetool
项目摘要
DESCRIPTION (provided by applicant): Sepsis, characterized by a systemic bacterial infection and systemic inflammatory response syndrome (SIRS), can lead to life-threatening conditions including multi-organ failure and septic shock. It has become increasingly apparent that the ability to effectively clear microorganisms may be one of the most important factors in preventing morbidity and mortality due to sepsis and septic shock. Neutrophils (PMN) play an essential role in this process. In response to a variety of mediators induced by microorganisms and acting through different pathways, PMN from the blood are attracted to the site of infection where they attempt to destroy the infectious agent by phagocytosis and the release of various lethal mediators. When carefully regulated this response is crucial to the host defense against microorganisms. However, when uncontrolled, PMN activation and infiltration can cause severe tissue damage and lead to complications such as acute respiratory distress syndrome (ARDS) and multiple organ failure. Despite its clinical importance, the regulation of neutrophil migration remains poorly understood. We have observed that E. coli that differ on the basis of expression of a K1 capsule use different mechanisms to escape the host's innate immune response. E. coli that lack a K1 capsule cause a delay in neutrophil recruitment early in infection, allowing these E. coli to divide and overwhelm the host before the neutrophils can get to the site of infection to clear the bacteria. In addition, we show that the LPS receptor, CD14, plays a major role in delaying the recruitment of PMN since deletion of this gene allows early recruitment and enhanced bacterial clearance. This enhanced clearance requires expression of TLR4, since deletion of TLR4 results in early PMN recruitment but no enhanced clearance. In contrast, infection with E. coli expressing a K1 capsule results in early PMN recruitment to the site of infection in the presence or absence of CD14 or TLR4, but early recruitment in this case does not aid in bacterial clearance since the K1 capsule makes these E. coli resistant to phagocytosis. The proposed studies are focused on defining the innate immune mechanisms that prevent or induce early neutrophil recruitment and bacterial clearance in severe infection by defining new pathways and receptors that regulate these critical biological functions. Understanding these molecular events will enable the development of more precise and effective tools for the treatment of sepsis and septic shock.
PUBLIC HEALTH RELEVANCE: Sepsis, characterized by a systemic bacterial infection, can lead to life-threatening conditions including multiorgan failure and septic shock. The neutrophil is an important cell that serves as a first line of defense against invading bacteria. This proposal aims to identify the molecules and mechanisms that regulate neutrophil recruitment to the site of infection.
描述(由申请人提供):脓毒症的特征是全身细菌感染和全身炎症反应综合征(SIRS),可导致危及生命的病症,包括多器官衰竭和脓毒性休克。越来越明显的是,有效清除微生物的能力可能是预防脓毒症和脓毒性休克发病和死亡的最重要因素之一。中性粒细胞(PMN)在此过程中发挥着重要作用。为了响应微生物诱导并通过不同途径起作用的各种介质,血液中的中性粒细胞被吸引到感染部位,在那里它们试图通过吞噬作用和释放各种致命介质来破坏感染原。当仔细调节时,这种反应对于宿主防御微生物至关重要。然而,如果不加控制,PMN 激活和浸润会导致严重的组织损伤,并导致急性呼吸窘迫综合征 (ARDS) 和多器官衰竭等并发症。尽管其临床重要性,中性粒细胞迁移的调节仍然知之甚少。我们观察到,基于 K1 胶囊表达的不同大肠杆菌使用不同的机制来逃避宿主的先天免疫反应。缺乏 K1 荚膜的大肠杆菌会导致感染早期中性粒细胞招募延迟,从而使这些大肠杆菌在中性粒细胞到达感染部位清除细菌之前分裂并压倒宿主。此外,我们发现 LPS 受体 CD14 在延迟 PMN 募集方面发挥着重要作用,因为删除该基因可以实现早期募集并增强细菌清除。这种增强的清除需要 TLR4 的表达,因为 TLR4 的缺失会导致早期 PMN 募集,但不会增强清除。相比之下,表达 K1 胶囊的大肠杆菌感染会导致在存在或不存在 CD14 或 TLR4 的情况下早期 PMN 募集到感染部位,但在这种情况下早期募集无助于细菌清除,因为 K1 胶囊使这些大肠杆菌对吞噬作用有抵抗力。拟议的研究重点是通过定义调节这些关键生物功能的新途径和受体,来定义预防或诱导严重感染中早期中性粒细胞募集和细菌清除的先天免疫机制。了解这些分子事件将使开发更精确和有效的工具来治疗脓毒症和脓毒性休克成为可能。
公共卫生相关性:脓毒症以全身细菌感染为特征,可导致危及生命的病症,包括多器官衰竭和脓毒性休克。中性粒细胞是一种重要的细胞,是抵御细菌入侵的第一道防线。该提案旨在确定调节中性粒细胞募集到感染部位的分子和机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sanna M Goyert其他文献
Sanna M Goyert的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sanna M Goyert', 18)}}的其他基金
CHARACTERIZATION OF THE LPS RECEPTOR FOR ACUTE PHASE
急性期 LPS 受体的特征
- 批准号:
6386492 - 财政年份:2000
- 资助金额:
$ 38.12万 - 项目类别:
CHARACTERIZATION OF THE LPS RECEPTOR FOR ACUTE PHASE
急性期 LPS 受体的特征
- 批准号:
6194383 - 财政年份:2000
- 资助金额:
$ 38.12万 - 项目类别:
CHARACTERIZATION OF THE LPS RECEPTOR FOR ACUTE PHASE
急性期 LPS 受体的特征
- 批准号:
6520033 - 财政年份:2000
- 资助金额:
$ 38.12万 - 项目类别:
MOLECULAR ANALYSIS OF MACROPHAGE ACTIVATION VIA LBP--LPS
LBP--LPS 激活巨噬细胞的分子分析
- 批准号:
2184577 - 财政年份:1992
- 资助金额:
$ 38.12万 - 项目类别:
MOLECULAR ANALYSIS OF MACROPHAGE ACTIVATION VIA LBP:LPS
通过 LBP:LPS 激活巨噬细胞的分子分析
- 批准号:
3306655 - 财政年份:1992
- 资助金额:
$ 38.12万 - 项目类别:
MOLECULAR ANALYSIS OF MACROPHAGE ACTIVATION VIA LBP:LPS
通过 LBP:LPS 激活巨噬细胞的分子分析
- 批准号:
3306656 - 财政年份:1992
- 资助金额:
$ 38.12万 - 项目类别:
CD14 AND OTHER LPS RECEPTORS AND ENDOTOXIN SHOCK
CD14 和其他 LPS 受体与内毒素休克
- 批准号:
2062363 - 财政年份:1989
- 资助金额:
$ 38.12万 - 项目类别:
CD14 AND OTHER LPS RECEPTORS AND ENDOTOXIN SHOCK
CD14 和其他 LPS 受体与内毒素休克
- 批准号:
2671871 - 财政年份:1989
- 资助金额:
$ 38.12万 - 项目类别:
ROLE OF CD14 AND OTHER LPS RECEPTORS IN ENDOTOXIC SHOCK
CD14 和其他 LPS 受体在内毒素休克中的作用
- 批准号:
6693442 - 财政年份:1989
- 资助金额:
$ 38.12万 - 项目类别:
ROLE OF CD14 AND OTHER LPS RECEPTORS IN ENDOTOXIC SHOCK
CD14 和其他 LPS 受体在内毒素休克中的作用
- 批准号:
7315275 - 财政年份:1989
- 资助金额:
$ 38.12万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Src Regulation of Lung Endothelial Barrier Function
Src 对肺内皮屏障功能的调节
- 批准号:
8059132 - 财政年份:2011
- 资助金额:
$ 38.12万 - 项目类别:
G-protein-induced Signaling of PMN-mediated Lung Injury
G 蛋白诱导的 PMN 介导的肺损伤信号转导
- 批准号:
7624162 - 财政年份:2002
- 资助金额:
$ 38.12万 - 项目类别:
G-protein-induced Signaling of PMN-mediated Lung Injury
G 蛋白诱导的 PMN 介导的肺损伤信号转导
- 批准号:
7826830 - 财政年份:2002
- 资助金额:
$ 38.12万 - 项目类别:
G-protein-induced Signaling of PMN-mediated Lung Injury
G 蛋白诱导的 PMN 介导的肺损伤信号转导
- 批准号:
7473229 - 财政年份:2002
- 资助金额:
$ 38.12万 - 项目类别: